Biosig Technologies (BSGM)
(Delayed Data from OTC)
$0.33 USD
-0.07 (-18.32%)
Updated Jun 18, 2024 03:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BSGM 0.33 -0.07(-18.32%)
Will BSGM be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for BSGM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BSGM
The Cooper Companies (COO) Q3 Earnings Match Estimates
BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model
BSGM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sientra (SIEN) Reports Q2 Loss, Lags Revenue Estimates
Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates
Hologic (HOLX) Tops Q3 Earnings and Revenue Estimates
Other News for BSGM
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
BioSig Technologies Announces CFO Transition and New Appointment
BioSig Technologies appoints Ferdinand Groenewald to interim CFO